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Tribulus macropterusAbstract The antihyperglycemic and antihyperlipidemic effects of the methanolic extracts of the
aerial parts of Cleome ramosissima Parl. (Cleomaceae), Barleria bispinosa (Forssk.) Vahl. (Acanth-
aceae) and Tribulus macropterus Boiss. (Zygophyllaceae) were evaluated in streptozotocin (STZ)
induced diabetic rats at a dose of 500 mg/kg bw. The reduction in fasting blood glucose level
(BGL) was observed in the following order C. ramosissima, B. bispinosa and T. macropterus at the
4th week of administration. C. ramosissima and T. macropterus also showed signiﬁcant increase
in plasma insulin by 100.6% and 189.9%, respectively. The studied plant extracts induced an
increase in both utilization and tolerance of glucose in diabetic rats. The hypolipidemic effect of
C. ramosissima and T. macropterus was demonstrated by a signiﬁcant reduction in plasma total
cholesterol (TC) (42.6% and 37.2%, respectively) and low density lipoprotein cholesterol
(LDL-C) (48.0% and 42.1%, respectively) and the increase of high density lipoprotein cholesterol
(HDL-C) by 81.0% and 91.9%, respectively. B. bispinosa decreased the blood levels of LDL-C
2 S.M. Ezzat et al.and increased the levels of HDL-C, while it did not affect the TC blood levels. The present data sug-
gest that C. ramosissima and T. macropterus have both antihyperglycemic and hypolipidemic effects
with high insulin-secreting activity.
ª 2014 Production and hosting by Elsevier B.V. on behalf of Faculty of Pharmacy, Cairo University.
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The worldwide epidemic of type 2 diabetes has been stim-
ulating the search for new concepts and targets for the
treatment of this incurable disease. Globally, the occurrence
of diabetes is estimated to increase, from 4% in 1995 to
5.4% by the year 2025.1 It has become a serious metabolic
disorder and is now one of the leading causes of death in
the world.
Diabetes mellitus, speciﬁcally type 2, is often associated
with dyslipidemia. Elevated levels of plasma free fatty acids
play a pivotal role by contributing signiﬁcantly to insulin
resistance. A patient with elevated low-density lipoprotein
(LDL) and decreased high density lipoprotein (HDL) will
have a high risk of experiencing cardiovascular disorders,2,3
that is why diabetic patients usually experience various vascu-
lar complications, such as atherosclerosis, diabetic nephropa-
thy and neuropathy.4 Treating dyslipidemia therefore will be
important to reduce macrovascular disorders in diabetic
patients.
Although several therapies are currently used in the treat-
ment of diabetes, draw backs such as cost, hypoglycemia,
weight gain, gastrointestinal disturbances, and liver toxicity
are major concerns to search for alternative approach or med-
icine to treat or control diabetes.5 On the other hand, tradi-
tionally used medicinal plants can provide an alternative
approach to treat diabetes. The available traditional medicines
(used to control or manage diabetes) contain a number of these
plants, this is because the plants are antioxidant rich therapies
and are virtually free of adverse effects.6 Fortunately, the
World Health Organization (WHO) has listed as many as
21,000 plants, which are used for medicinal purposes around
the world.
It is also noteworthy to mention that many plants are con-
sidered valuable antidiabetic drugs, for instance the oral
administration of the methanol extract of the aerial parts of
Barleria lupulina Lindl. (Acanthaceae) exerted a signiﬁcant
hypoglycemic effect in STZ-induced hyperglycemia in rats.7
On the other hand, Cleome droserifolia (Forssk.) Del. (Cleom-
aceae) has also been reported to be a famous antihyperglyce-
mic agent.8–13 In addition, the genus Tribulus is rich in
steroidal glycosides,14 these compounds are reported to be ac-
tive antidiabetic agents.15,16
Therefore, in our program of biological screening of plants
growing in the western region of the Kingdom of Saudi Arabia
for their Antidiabetic activity, and regarding the chemotaxo-
nomical point of view it was found logic to choose plants of
the same genera as those proving antidiabetic activity, such
as Barleria bispinosa, Cleome ramosissima, and Tribulus macr-
opterus for their antidiabetic activity, especially because the
preliminary phytochemical screening showed similarities be-
tween the chemical composition of our plants and that of the
aforementioned species.2. Materials and methods
2.1. Chemicals
Streptozotocin (STZ) and a-D-glucose were purchased from
Sigma–Aldrich (St Louis, MO, USA). Carboxymethylcellulose
sodium (CMC-Na) was purchased from Acros Organics (NJ,
USA), while heparin sodium was purchased from Merck,
(Darmstadt, Germany). Insulin kit (Coat-A-Count Insulin)
was purchased from Siemens, Medical Solutions Diagnostics
(Los Angeles, USA). All other biodiagnostic kits were pur-
chased from Diagnostic and Research Reagents (Giza, Egypt).
2.2. Plant material and extraction
The aerial parts of C. ramosissima Parl., B. bispinosa (Forssk.)
Vahl. and T. macropterus Boiss. were collected from Al-Hadda
road, Al-Baha and Jeddah, respectively, Saudi Arabia, in
March 2008 and were dried in shade. A specimen of each plant
was deposited in the herbarium of college of Pharmacy, King
Abdulaziz University, Jeddah, Saudi Arabia (CR1040, BB1002
and TM1162, respectively). The powdered plant material
(500 g) in each case was extracted with methanol using Ultra-
turrax T25 homogeniser (Janke & Kunkel, IKA Labortechnik,
Stauten, Germany) (3 · 2000 ml). The vehicle was distilled off
under reduced pressure and the dried methanol extract was
kept at 4 C.
2.3. Phytochemical screening
The methanol extracts of the aerial parts of C. ramosissima,
B. bispinosa and T. macropterus were screened for carbohy-
drates and/or glycosides, ﬂavonoids, tannins, saponins
and/or triterpenes and alkaloids through applying various
chemical tests.17
2.4. Animals
Male Wister rats, weighing 150–200 g, were used in this study
in accordance with the guidelines of the Biochemical and
Research Ethics Committee at the King Abdulaziz University,
Jeddah, Saudi Arabia. Animals were purchased from the ani-
mal house of the King Fahed Medical Research Center, King
Abdulaziz University. Animals were housed for two days un-
der standard conditions (well ventilated, temperature
22 ± 2 C, relative humidity 50–60% and 12 h day and night
cycle). Food consisted of normal rat chow and water was pro-
vided ad libitum. Care was taken to avoid stressful conditions.
All experimental procedures were performed between 8 and
10 a.m. All the experimental works with the animals were
carried out after obtaining approval from the Institutional
Animal Ethics Committee.
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Antihyperglycemic and antihyperlipidemic effects of the methanol extracts of Cleome ramosissima 32.5. Acute toxicity study
Twenty-four adult male Wister rats were used to test the meth-
anol extract of each plant and the animals of each group were
divided into four subgroups (n= 6) and received increasing
doses of 100, 250, 500, and 1000 mg/kg body weight daily for
a period of 3 weeks. The animals were observed during the ﬁrst
hour continuously and then every hour for 6 h, then after 12
and 24 h, and ﬁnally after every 24 h up to 3 weeks for any
physical signs of toxicity such as writhing, gasping, palpitation
and decreased respiratory rate or mortality.18
2.6. Evaluation of the effects of C. ramosissima, B. bispinosa and
T. macropterus on hyperglycemic rats
2.6.1. Induction of diabetes
Diabetes was induced by an intraperitoneal (ip) injection of a
fresh solution of a single dose of STZ (in 0.1 M sodium citrate
buffer, pH 4.5) in a dose of 55 mg/kg body weight, to over-
night fasting rats.19 Ten days after STZ administration, rats
with fasting blood glucose levels (BGL) between 20 and
30 mmol/L (360–540 mg/dl) were selected and divided into 5
groups (groups II – VI) eight rats each.
2.6.2. Experimental design
Group I: Animals of this group were served as normal control
and received an equivalent volume of the 0.1 M sodium citrate
buffer.
Group II: Animals of this group were STZ-induced diabet-
ics, received a single daily dose of 1% CMC-Na starting at the
11th day, and this group served as the control diabetic group.
Group III: Animals of this group were diabetics and re-
ceived a single daily dose of glibenclamide in a dose of 5 mg/
kg starting at the 11th day and served as the glibenclamide-
treated group.
Group IV–VI: Diabetic rats received the methanol extracts
of C. ramosissima, B. bispinosa and T. macropterus, respec-
tively, in a dose of 500 mg/kg body weight each as single daily
dose starting at the 11th day. The doses of the extracts were
determined as 500 mg/kg/day from preliminary short-term
pilot study with a range of variable doses in our laboratory.
Vehicle, glibenclamide and plant extracts were given orally
(po) by gavage as single daily treatments for 4 weeks. Blood
samples were collected from tail vein and fasting BGL of the
overnight fasted animals was measured before the treatment
and at days 7, 14, 21 and 28 from the treatment.
2.6.3. Estimation of plasma glucose and tissue glycogen
Fasting plasma glucose was estimated using the glucose oxi-
dase peroxidase method.20 The results are presented in Table 1.
2.6.4. Oral glucose tolerance test (OGTT)
At the end of the 28th day, 3 h after the last dose of the vehicle,
glibenclamide or the extract, blood samples were withdrawn
from tail vein of overnight fasting rats and BGL was deter-
mined, indicating zero time of the test. Glucose solution
(50%) in a dose of 2.5 g/kg was given orally.21 Blood samples
were withdrawn at 15, 30, 60, 90 and 120 min after glucose
loading and BGL was determined at these time intervals using
One Touch Ultra. Curves of BGL (mg/dl) versus the time
Table 3 Effects of oral administration of the tested plant
extracts (500 mg/kg) on plasma insulin levels in diabetic rats.
Treatment Insulin (lIU/ml) % Change
Normal control 7.48 ± 1.32
Diabetic control 3.22a ± 0.387 56.9
DR+Glibenclamide 12.47b ± 2.39 +272.7
DR+ Cleome ramosissima 6.47b ± 0.67 +100.6
DR+ Barleria bispinosa 1.91b ± 0.34 41.0
DR+ Tribulus macropterus 9.35b ± 0.93 +189.9
The values are expressed as the mean ± SE of the mean.
DR: diabetic rats.
a Signiﬁcantly different from the values of the normal rats at
P< 0.05.
b Signiﬁcantly different from the control values of diabetic rats at
P< 0.05.
4 S.M. Ezzat et al.intervals (min) constructed and the area under the curve
(AUC) was calculated by the trapezoidal method. The AUCs
of the curves of each group were compared and tested for sig-
niﬁcance from the control-diabetic group, to represent the glu-
cose tissue utilization. The results are recorded in Table 2.
2.6.5. Estimation of plasma insulin level
At the end of the 28th day, 3 h after the last dose of the vehicle,
glibenclamide or the extracts, blood samples were withdrawn
from the orbital sinus of rats under light ether anesthesia into
heparinized tubes. Samples were centrifuged at 3500g for
15 min for separation of plasma. Plasma samples were sepa-
rated and kept at 20 C for analysis when required. Insulin
concentrations were determined by radioimmunoassay proce-
dure using insulin kits. The results are presented in Table 3.
2.6.6. Estimation of plasma lipid proﬁle
At the end of the 28th day, blood lipids were determined using
spectrophotometric assay techniques. Plasma of normal (group
I), diabetic control (group II) and diabetic-treated (groups III–
VI) rats was used for the determination of plasma TC, TG,
LDL-C and HDL-C. The results are tabulated in Table 4.
2.7. Statistical analysis
Data are expressed as mean ± standard error (SE) of mean.
Unless otherwise indicated, statistical analyses were performed
using the one-way analysis of variance (ANOVA). If the over-
all F-value was found statistically signiﬁcant (P< 0.05), fur-
ther comparisons among groups were made according to
post hoc Tukey’s test. All statistical analyses were performed
using SPSS GraphPad InStat 3 (GraphPad Software, Inc.
La Jolla, CA, USA) software.
3. Results
3.1. Phytochemical screening
The methanol extracts of the aerial parts of C. ramosissima,
B. bispinosa and T. macropterus were proved to contain
glycosides, ﬂavonoids, tannins and triterpenes, in addition the
methanol extract of T. macropterus gave positive test for
saponins.Table 2 Total area under the curve induced after glucose
loading in diabetic rats pretreated with the tested plant extracts
(500 mg/kg/day) for 4 weeks.
Groups Total AUC (mg/dl.min)
(X ± SE)
%
Reduction
Normal rats 14,479 ± 480.42 –
Diabetic rats 70,108 ± 2077.06 0.00
DR+ Glibenclamide 59,692a ± 1785.26 15%
DR+ Cleome ramosissima 53,947a ± 5303.16 23%
DR+ Barleria bispinosa 57,375a ± 3971.31 18%
DR+ Tribulus macropterus 60,675a ± 2091.27 19%
DR: diabetic rats.
a Signiﬁcantly different from the control values of diabetic rats at
P< 0.05.3.2. Toxicity study
No deaths were reported in the rats treated with different doses
of the methanol extract of C. ramosissima, B. bispinosa and T.
macropterus and rats did not show any apparent physical signs
of drug-induced toxicity during the whole experimental period.
3.3. Effect of extracts on plasma glucose level
STZ-diabetic rats showed signiﬁcant increase in the levels of
plasma glucose when compared to normal rats. Glibenclamide
treatment of diabetic rats showed signiﬁcant reduction in the
plasma glucose level at 21st day of treatment compared to be-
fore treatment. On the other hand, oral administration of C.
ramosissima extract signiﬁcantly decreased the blood glucose
levels. These effects started at the 2nd week of treatment and
continued till the end of the 4th week and recorded 23%,
31% and 37% decrease compared to before treatment (Ta-
ble 1). Similarly, B. bispinosa and T. macropterus produced sig-
niﬁcant reductions in blood glucose levels, started after the 3rd
week of treatment and continued till the 4th week, (14% and
19%) and (31% and 30%), respectively (Table 1).
3.4. Effect of extracts on OGTT
The blood levels of glucose in control, diabetic group, diabetic-
treated with glibenclamide or plant extract groups demon-
strated a signiﬁcant change in BGL after oral loading with
50% glucose solution. The rats of the diabetic group had a sig-
niﬁcant elevation in BGL throughout the total measurement
period (120 min) with respect to normal control, also it did
not come back to the initial value (0 min level) even at the
end of the period tested (120 min).
Pretreatment of diabetic rats with gibenclamide induced a
signiﬁcant reduction (15%) in the AUC relative to the diabetic
control group. However, pretreatment of the diabetic rats with
C. ramosissima, B. bispinosa and T. macropterus produced sig-
niﬁcant reductions of the AUCs (Table 2). These reductions
were as follows, 23%, 18%, and 14%, respectively.
3.5. Effect of extracts on plasma insulin level
The induction of diabetes signiﬁcantly reduced the plasma insu-
lin level by 56.9% (Table 3). After 4 weeks of po administration
Table 4 Effects of oral administration of the tested plant extracts (500 mg/kg) on total cholesterol, triglycerides, high density
lipoprotein and low density lipoprotein in diabetic rats.
Treatment Total cholesterol
(TC) (mg/dL)
%
Change
Triglycerides
(TG) (mg/dL)
%
Change
High density
lipoprotein
cholesterol
(HDL-C) (mg/dL)
%
Change
Low density
lipoprotein
cholesterol
(LDL-C) (mg/dL)
% Change
Normal control 125.71 ± 4.04 87 ± 2.52 29.57 ± 5.47 78.70 ± 4.58
Diabetic control* 239.99a ± 21.53 +90.9 113.33a ± 11.15 +30.3 20.56 ± 3.09 32.4 168.68 ± 8.75 +114.3
DR+ glibenclamide 178.28a ± 15.05 25.7 121.6 ± 14.62 +7.3 41.84a ± 7.15 +103.2 112.10 ± 8.02 33.5
DR+ Cleome ramosissima 139.04a ± 8.81 42.2 109.60 ± 11.70 3.3 37.23a ± 5.66 +81.0 87.70a ± 14.05 48.0
DR+ Barleria bispinosa 189.71 ± 15.05 21.7 89.33 ± 11.85 21.2 40.44a ± 6.77 +96.7 119.96a ± 15.77 28.9
DR+ Tribulus macropterus 150.85a ± 21.04 37.2 90.00 ± 6.22 20.6 39.46a ± 5.84 +91.9 97.68a ± 26.79 42.1
The values are expressed as the mean ± SE of the mean.
DR: diabetic rats.
* Signiﬁcantly different from the values of the normal rats at P< 0.05.
a Signiﬁcantly different from the control values of Diabetic rats at P< 0.05.
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272.7% of diabetic control was produced. However, Oral
administration of C. ramosissima and T. macropterus extracts
signiﬁcantly increased the insulin blood levels compared to
the diabetic rats by 100.6% and 189.9%, respectively. On the
other hand, B. bispinosa extract signiﬁcantly decreased the
blood levels of insulin by 41% of diabetic rats.
3.6. Effect of extracts on plasma lipid proﬁle
Diabetic rats showed signiﬁcant increase in the blood levels of
TC, TG and LDL-C (Table 4). The recorded increases were
90.9%, 30.3% and 114.3%, respectively of the values of the
normal rats. On the other hand, HDL-C was signiﬁcantly re-
duced by 32.4% of the value of the normal rats. Oral admin-
istration of glibenclamide signiﬁcantly decreased the blood
levels of TC and LDL-C by 25.7% and 33.5% of the diabetic
rats, respectively. However, the level of HDL-C signiﬁcantly
increased by 103.2%. Glibenclamide did not signiﬁcantly
change the blood level of TG. Administration of C. ramosiss-
ima to diabetic rats signiﬁcantly reduced the blood levels of
both TC and LDL-C by 42.2% and 48.0%, respectively, while
the HDL-C level increased by 81.0%. B. bispinosa signiﬁcantly
decreased the blood levels of LDL-C by 28.9%, while it did not
affect the TC and TG blood levels. On the other hand, it sig-
niﬁcantly increased the levels of HDL-C by 96.7%. Adminis-
tration of T. macropterus to diabetic rats signiﬁcantly
decreased the blood levels of TC and LDL-C by 37.2% and
42.1%, relative to the diabetic control rats, respectively. It sig-
niﬁcantly increased the blood level of HDL-C by 91.9% of the
control diabetic rats.4. Discussion
Non-insulin dependent diabetes mellitus or type 2 diabetes is
the much more prevalent form of diabetes accounting for more
than 90% of all diabetes cases and causes serious socioeco-
nomic problems especially in developing countries.22
This investigation aimed at studying the antihyperglycemic
and hypolipidemic effects of the methanol extracts of C. ramo-
sissima,T.macropterus, andB. bispinosa on STZ-induced diabe-
tes in rats, especially that the toxicity study proved the safety of
these extracts. STZ is commonly used laboratory chemical toinduce experimental type 2 diabetes in animals. STZ mediated
alkylation of pancreatic deoxyribonucleic acid causes the gener-
ation of superoxide, hydrogen peroxide, nitric oxide and hydro-
xyl radicals which are responsible for b-cells damage and
necrosis resulting in diabetes.23 Therefore, in our study STZ-dia-
betic rats showed signiﬁcant increase in the levels of plasma glu-
cose when compared to normal rats. Findings of the present
work concerning the anti-hyperglycemic effect ofC. ramosissima
are in agreement with those reported by Nicola et al. (1996)10,
who reported that the extract ofC. droserifolia signiﬁcantly sup-
pressed the rise in peripheral blood glucose concentrations, both
in the basal (fasting) state and after glucose intake.
Similarly, B. bispinosa and T. macropterus produced signif-
icant reductions in blood glucose levels, which started after the
3rd week of treatment and continued till the 4th week, these
also were in accordance with the reported data, where the level
of serum glucose signiﬁcantly reduced after administration of
saponin fraction isolated from Tribulus terrestris, by 26.25%
and 40.67% in normal and diabetic mice, respectively.16 In an-
other study, the decoction (saponin rich fraction) of T. terres-
tris signiﬁcantly inhibited the gluconeogenesis and inﬂuenced
glycometabolism on normal mice.24
The plant extracts subjected to this study can be arranged
in a descending order according to their possible capability to
reduce the blood glucose level and hence their possible
antidiabetic activities as follows: C. ramosissima, T. macropte-
rus and B. bispinosa. As regards to the antihyperglycemic
activity of glibenclamide at the selected dose levels, the
extracts of C. ramosissima showed higher activity; while T.
macropterus exhibited similar activity, however, B. bispinosa
demonstrated, a lower antihyperglycemic activities than
glibenclamide.
The effect of the tested extracts on glucose tolerance and
glucose tissue utilization was studied in diabetic rats. Glu-
cose loading was done 3 h after the administration of vehi-
cle, glibenclamide and the extracts. Induction of diabetes
produced a signiﬁcant increase of the AUC to 70,108 vs
14,479 mg/dl/min of normal rats (Table 2). This indicated
the reduction of glucose tissue utilization, increased hepatic
glucose production and hyperglycemia. Pretreatment of dia-
betic rats with C. ramosissima, B. bispinosa and T. macropte-
rus produced signiﬁcant reductions of the AUCs. These
results revealed that the studied plant extracts induced an
increase in glucose utilization and glucose tolerance. In
6 S.M. Ezzat et al.addition, these extracts may also reduce gluconeogenesis.
This was approved after the determination of plasma level
of insulin at the end of the experiment.
Induction of diabetes signiﬁcantly reduced the blood insulin
levels, this effect may be due to the ability of STZ in the given
dose to induce partial damage of the pancreatic b-cells,25 as
STZ was reported to induce a dose-dependent damaging effect
on pancreatic b-cells.26 Oral administration of C. ramosissima
and T. macropterus extracts for 4 weeks signiﬁcantly increased
the insulin blood levels, compared to the diabetic rats and this
may be through stimulation of the activity of the remnant pan-
creatic b-cells.
Hyperlipidemia is one of the major cardiovascular risk fac-
tors. It has been demonstrated that insulin deﬁciency in diabetes
mellitus leads to a variety of derangements inmetabolic and reg-
ulatory processes, which in turn leads to accumulation of lipids
such as TG and TC in diabetic patients,27 for this reason, the
induction of diabetes in rats in the present study signiﬁcantly in-
creased the blood levels of total cholesterol (TC), triglycerides
(TG) and low density lipoprotein cholesterol (LDL-C), while
the high density lipoprotein cholesterol (HDL-C) signiﬁcantly
reduced (Table 4). These ﬁndings are in accordance with that re-
ported by Felix et al. (2001).28 In normal condition, insulin in-
creases the receptor-mediated removal of LDL-C and
therefore a decrease in insulin activity during diabetes causes
hypercholesterolemia. Administration of the methanol extracts
ofC. ramosissima,B. bispinosa andT.macropterus for 4 weeks to
diabetic rats improved the lipid proﬁle almost to the normal lev-
els (Table 4). One of the most common side effects of some
antihyperlipedemic drugs, that decrease TC, is the reduction of
the cardioprotective HDL-C.29 Interestingly, C. ramosissima,
B. bispinosa and T. macropterus not only lowered TC and
LDL levels, but also increased HDL-C level.
In conclusion, C. ramosissima, B. bispinosa and T. macr-
opterus exhibited antihyperglycemic activity. The possible
mechanism by which these plants bring about their antidia-
betic activity may be through stimulation of the activity of
the remnant pancreatic ß-cells (synthesis, release, cell regener-
ation/revitalization), the insulin-like activity of the plant ex-
tracts or the increase of glucose uptake in lipocytes. Their
hypolipidemic effect may be due to the low activity of choles-
terol biosynthesis enzymes and/or low level of lipolysis, which
are under the control of insulin. Hypolipidemic effects could
prevent or be helpful in reducing the complications of lipid
proﬁle seen in some cases of diabetes in which hyperglycemia
and hypercholesterolemia coexist.
All of these actions may be responsible for the reduction
and/or abolition of diabetic complications. The plants could
be also regarded as potential antihyperlipidemic agents that
may need further studies to be established.
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